European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from AI-exposed momentum stocks.
Investment firms for the world’s ultra-wealthy diverged over their stance on Oracle Corp. during a period when the US software giant’s stock rallied the most…